ALLE vs BTAI · P/E 21, rev $2.19B vs rev $388.0K
Allegion PLC (ALLE) versus BioXcel Therapeutics Inc (BTAI) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. BTAI currently screens at market cap $36.1M.
Not investment advice. Open the ALLE and BTAI stock pages for the full models.
Not investment advice.